Unveiling therapeutic targets and preventive components for kidney insufficiency and blood stasis-type BPH: bridging metabolomics, network pharmacology and reverse screening

Benign prostatic hyperplasia (BPH) is a common disease affecting male urinary system function and quality of life, with its incidence increasing due to population ageing and unhealthy lifestyles. Modern medicine mainly adopts symptomatic treatments such as 5-alpha reductase inhibitors and alpha1 adr...

Full description

Bibliographic Details

Published in:	Frontiers in Pharmacology
Main Authors:	Xiangpeng Kong, Haiqin Ren, Ke Pei, Yajun Yao, Zhigang Liang, Yunfeng Xue, Shuang Liang, Tongtong Li, Jing Zhang, Yuxia Guo, Miaorong Pei, Huifeng Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Subjects:	benign prostatic hyperplasia (BPH) kidney insufficiency and blood stasis metabolomics network pharmacology integration target
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1584766/full